Company news

Bionano Genomics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Bionano Announces Peer-Reviewed Publication from its Clinical Study Designed to Support OGM as Part of Standard of Care (SOC) in Genetic Disease Testing

January 10, 2024

Bionano Announces 2024 Symposium: Four Consecutive Days of OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications

January 9, 2024

Bionano Reports Preliminary Fourth Quarter and Full-Year 2023 Results

January 7, 2024

Bionano Announces Significant Upgrades to its Bionano Solve Pipeline and its VIA™ Software for OGM Data Analysis in Constitutional Genetic Disease Research

December 27, 2023

Bionano Announces Publication of Largest Prospective Prenatal Study Comparing OGM to Chromosomal Microarray Analysis and Karyotyping

December 25, 2023

Bionano Laboratories Announces Publication of the Analytical Validation of its OGM-Based Laboratory Developed Test for Hematological Malignancies and Additional Multi-Site Technical Evaluation of OGM

December 11, 2023

Bionano Announces Presentations Featuring OGM Utility Across Blood Cancer Research at the American Society of Hematology (ASH) Annual Meeting

December 5, 2023

Bionano Announces Publication Demonstrating Utility of OGM to Assess Genome Integrity of CRISPR-Edited Cells as Part of Gene Therapy Development

November 28, 2023

Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting

November 13, 2023

Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress

November 7, 2023

Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023

October 31, 2023

Bionano Announces Presentation of OGM Utility Across Key Applications at the American Society of Human Genetics (ASHG) Annual Meeting

October 25, 2023

Bionano Prices $80.0 Million Financing in Convertible Notes and Warrants, Announces Preliminary Q3 2023 Results, and Implements Streamlined Operational Plan

October 10, 2023

Bionano Announces Pricing of $80.0 Million Registered Offering and Concurrent Private Placement of Senior Secured Convertible Notes and Warrants

October 10, 2023

Bionano Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

September 21, 2023

Bionano Announces Third OEM Partner has Received China NMPA Approval for DNA Isolation Products for IVD Use of OGM

September 20, 2023

Bionano Announces Peer-Reviewed Publication on the Utility of Combining OGM and WES for Evaluation of Pediatric Leukemia

September 5, 2023

Bionano Announces Publication Demonstrating Utility of OGM as an Alternative to KT and CMA for Evaluating CRISPR-Edited Cells as Part of Stem Cell Therapy Development

August 29, 2023

Bionano Announces Second OEM Partner has Received China NMPA Approval for DNA Extraction and Labeling Products for IVD Use of OGM in Reproductive Health

August 27, 2023

Bionano Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement

August 20, 2023

Bionano Laboratories Receives College of American Pathologists (CAP) Accreditation for its Clinical Laboratory

August 15, 2023

Bionano Announces CFO Transition and Appointment of Gülsen Kama as Chief Financial Officer

August 13, 2023

Bionano Announces Presentation of Optical Genome Mapping (OGM) Utility Across Cancer Research Applications at the Cancer Genomics Consortium (CGC) 2023 Annual Meeting

August 10, 2023

Bionano Reports Second Quarter 2023 Results and Highlights Recent Business Progress

August 8, 2023

Bionano Genomics Announces Reverse Stock Split

August 3, 2023

Bionano Announces OGM Roadshow, TOUR, which Provides Education on the Company’s Workflow and Helps Build a Community of Users

July 30, 2023

Bionano Announces the Stratys™ System for OGM and VIA™ Software for Hematologic Malignancies

June 28, 2023

Bionano Announces Peer-Reviewed Publication on the Utility of Combining OGM and a 523-gene NGS Panel for Standard Evaluation of Myeloid Cancers

June 19, 2023

Bionano Announces Results from its Annual Meeting of Stockholders

June 13, 2023

Bionano Announces 2023 Winners of its Innovator Research Grant Program

June 11, 2023

Bionano Announces Extensive Lineup of Content at European Conferences Featuring OGM Utility Across a Broad Range of Research Applications

June 7, 2023

Bionano Announces Commercial Release of New Kits for its Ionic System featuring New Chemistry for Nucleic Acid Extraction from FFPE and Tumor Tissue

June 5, 2023

Bionano Reports First Quarter 2023 Results and Highlights Recent Business Progress

May 8, 2023

Bionano to Report First Quarter 2023 Financial Results and Host a Conference Call and Webcast on May 9, 2023

May 1, 2023

Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal

April 30, 2023

Bionano Announces Three Publications Demonstrating OGM’s Utility for Hematological Malignancy Research

April 25, 2023

Bionano Announces Preliminary Q1 2023 Results and Business Updates

April 23, 2023

Bionano Announces Presentation of OGM Utility Across Cancer Genomics Research Applications at the American Association for Cancer Research (AACR) Annual Meeting

April 12, 2023

Bionano Announces Publication that Demonstrates OGM’s Utility for Resolving Complex Genetic Variation in Inherited Retinal Disease

April 5, 2023

Bionano Announces First Study Using OGM to Discover Structural Variants with Potential Relevance to Genetic Diagnosis of MRKH Syndrome, a Syndrome Impacting Reproductive System Development in 1 in 4,500 Females

March 21, 2023

Bionano Laboratories Expands its Clinical Testing Menu with Launch of OGM-Based Laboratory Developed Tests (LDTs) for Prenatal and Postnatal Analysis

March 14, 2023

Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Featuring OGM Utility Across a Broad Range of Research Applications

March 12, 2023

Bionano Genomics Reports Fourth Quarter and Full-Year 2022 Results and Provides Revenue Outlook for 2023

March 8, 2023

Bionano Announces Two Publications from its Clinical Study Designed to Support OGM as Part of Standard of Care (SOC) in Genetic Disease Testing including the First Peer-Reviewed Publication on the Multi-Site Evaluation of OGM Against SOC

March 1, 2023

Bionano to Report Fourth Quarter and Year End 2022 Financial Results and Host a Conference Call and Webcast March 9, 2023

February 28, 2023

Bionano Announces China NMPA Approval for DNA Extraction and Labeling Products for IVD Use in Hematologic Malignancies

February 21, 2023

Bionano Laboratories Expands its Clinical Testing Menu with Launch of its First OGM-Based Laboratory Developed Test (LDT) for Hematological Malignancies

January 23, 2023

Bionano Announces Launch of Next-Generation Versions of its Reagent Kits and Chip Consumable, Along with Updates to its Instrument Control and Bionano Access Software for the Optical Genome Mapping Workflow

January 22, 2023

Bionano Genomics Announces the Final Speaker Lineup for Symposium 2023 with 30 OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Research Applications

January 19, 2023

Bionano Announces Publication of Interim Readout from Clinical Trial Run by Consortium Analyzing Optical Genome Mapping as Potential Standard of Care for Prenatal Testing

January 17, 2023

← Newer news releases · Older news releases →

Calls

The 5 newest of 24 calls. Every call is listed under its year.

Decks

The 5 newest of 18 decks. Every deck is listed under its year.